ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

Group 1 - ANI Pharmaceuticals, Inc. has initiated closing logistics for the acquisition of Alimera Sciences, Inc. and expects to finalize the acquisition today, pending customary closing conditions [1] - ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, particularly for diseases with high unmet medical needs [2] - The company aims to achieve sustainable growth by expanding its Rare Disease business, enhancing its Generics business through improved R&D capabilities, and leveraging its U.S.-based manufacturing footprint [2]